• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by XWELL Inc.

    5/15/26 4:05:10 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary
    Get the next $XWEL alert in real time by email
    NT 10-Q 1 tm2614685d2_nt10q.htm NT 10-Q

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 12b-25

     

    NOTIFICATION OF LATE FILING

     

    (Check One): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-CEN ¨ Form N-CSR
       
      For Period Ended: March 31, 2026
       
      ¨ Transition Report on Form 10-K
      ¨ Transition Report on Form 20-F
      ¨ Transition Report on Form 11-K
      ¨ Transition Report on Form 10-Q
      For the Transition Period Ended: ________________________

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

     

    PART I - REGISTRANT INFORMATION

     

    XWELL, INC.

    Full name of Registrant

     

    Former Name if Applicable

     

    254 West 31st Street, 11th Floor

    Address of Principal Executive Office (Street and Number)

     

    New York, New York 10001

    City, State and Zip Code

     

     

     

     

     

     

    PART II - RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

     

    x   (a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
      (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
      (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

    PART III - NARRATIVE

     

    State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

     

    XWELL, Inc. (the “Company”) will not, without unreasonable effort and expense, be able to file its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”), within the prescribed time period. Additional time is needed for the Company to compile and analyze supporting documentation in order to complete its financial statement preparation and review process to finalize the Form 10-Q. The Company anticipates that it will file the Form 10-Q no later than the fifth calendar day following the prescribed filing date.

     

    PART IV - OTHER INFORMATION

     

    (1) Name and telephone number of person to contact in regard to this notification

     

    Ezra T. Ernst   646.389.3412
    (Name)   (Area Code) (Telephone Number)

     

    (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). x Yes ¨ No
       
       
    (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ¨ Yes x No

     

    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

     

     

     

     

    XWELL, INC.

    (Name of Registrant as Specified in Charter)

     

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date May 15, 2026   By: /s/ Ezra T. Ernst
            Name: Ezra T. Ernst
            Title: Chief Executive Officer

     

     

     

    Get the next $XWEL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $XWEL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $XWEL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wizenberg Gaelle Sandra bought $1,987 worth of shares (1,201 units at $1.65), increasing direct ownership by 402% to 1,500 units (SEC Form 4)

    4 - XWELL, Inc. (0001410428) (Issuer)

    9/13/24 5:41:59 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    Director Wizenberg Gaelle Sandra bought $551 worth of shares (299 units at $1.84) (SEC Form 4)

    4 - XWELL, Inc. (0001410428) (Issuer)

    7/22/24 8:47:43 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    SEC Filings

    View All

    SEC Form 10-Q filed by XWELL Inc.

    10-Q - XWELL, Inc. (0001410428) (Filer)

    5/20/26 4:05:39 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    SEC Form NT 10-Q filed by XWELL Inc.

    NT 10-Q - XWELL, Inc. (0001410428) (Filer)

    5/15/26 4:05:10 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form 10-K/A filed by XWELL Inc.

    10-K/A - XWELL, Inc. (0001410428) (Filer)

    4/30/26 4:12:23 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    XWELL Reports Fiscal 2025 Results

    NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced financial results for the year ended December 31, 2025. Recent Operating Highlights XWELL delivered 2025 revenue of approximately $29.2 million.Total operating expenses decreased by approximately 10% versus the comparable prior year period.Cost of sales decreased approximately 13% versus 2024.  General and administrative expenses decreased approximately 20% year-over-year.In December 2025, the Company opened a new wellness retail location in New York City's Pennsylvania Station.In February 2026, XWELL entered int

    4/1/26 4:30:00 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    AI Biotech, APAC Expansion, and Balance Sheet Rebuilds Set the Morning Tone

    DENVER, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Markets are opening with a strong crosscurrent of AI-powered drug discovery, cross-border biologics distribution, and capital structure resets. From micro-cap transformation stories to cash-rich TechBio platforms, this morning's tape highlights companies positioning for scale in 2026 and beyond. Totaligent Targets APAC Biologics and Medical Tourism Totaligent (OTCID: TGNT) announced the execution of a binding Letter of Intent (LOI) with GloMed Solutions Limited Liability Company, a Japanese medical aesthetics and biologics distributor, to form a joint venture integrating Totaligent's recently announced Aetherium Medical platform. The agreement e

    2/25/26 9:38:05 AM ET
    $NXPL
    $RXRX
    $XWEL
    Telecommunications Equipment
    Telecommunications
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    XWELL Announces Approximately $31.3 Million Private Placement Priced At The Market Under Nasdaq Rules

    NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a provider of wellness and biosecurity solutions, today announced that it has entered into a securities purchase agreement with a series of American Ventures, LLC in a private placement that is expected to result in gross proceeds to the Company of approximately $31.3 million, before deducting placement agent fees and offering expenses. The private placement consists of the sale of, (i) approximately 31,333 shares of Series H Convertible Preferred Stock, with a stated value of $1,000 per share, convertible into an aggregate of 66,666,669 shares of common stock of the Company at an initial con

    2/24/26 4:15:00 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Weinstein Robert was granted 100,000 shares, increasing direct ownership by 87% to 215,231 units (SEC Form 4)

    4 - XWELL, Inc. (0001410428) (Issuer)

    3/2/26 7:45:36 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    Director Lebowitz Michael was granted 100,000 shares, increasing direct ownership by 90% to 211,122 units (SEC Form 4)

    4 - XWELL, Inc. (0001410428) (Issuer)

    3/2/26 7:43:54 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    President and CEO Ernst Ezra was granted 100,000 shares, increasing direct ownership by 99% to 201,130 units (SEC Form 4)

    4 - XWELL, Inc. (0001410428) (Issuer)

    3/2/26 7:43:16 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    Leadership Updates

    Live Leadership Updates

    View All

    XWELL Reaffirms Commitment to Biosecurity, Appoints Former CDC Senior Advisor

    NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced the continued expansion of its global biosecurity strategy, leveraging its traveler-based pathogen surveillance capabilities to support international travel hubs and large-scale mass gathering events worldwide. To support this next phase of growth, XWELL announced today that Cindy Friedman, M.D., former CDC senior advisor and the founding director of CDC's Traveler-based Genomic Surveillance (TGS) program, will serve as a senior advisor to the Company. In this role, Dr. Friedman will provide strategic guidance on t

    1/8/26 8:00:00 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL Expands Florida Presence with Grand Opening of Waterford Lakes Wellness Center on September 5

    ORLANDO, Fla., Aug. 28, 2025 (GLOBE NEWSWIRE) -- XWELL (NASDAQ:XWEL) ("XWELL" or the "Company"), a leader in wellness solutions for people on the go, is pleased to announce the grand opening of its newest Florida wellness center at Orlando's Waterford Lakes Town Center on Thursday, September 5. The celebration will feature live demonstrations, skincare consultations, and special participation from the Orlando Magic, which recently named XWELL its official wellness spa. You're Invited: Celebrate with UsGuests are invited to join XWELL for an official ribbon-cutting and a first look at the Orlando area's newest destination for self-care: Date: Thursday, September 5Time: 3:00 PM – 7:00 PM E

    8/28/25 8:00:00 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL Launches All-New Website, Offering Seamless Booking and Unified Access to Health, Wellness & Beauty Services

    NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL), a leading provider of wellness solutions for people on the go, today unveiled its newly redesigned website — a digital destination that integrates all of the company's services and offerings, allowing customers to discover, book, and engage through a seamless, user-first experience. Accessible at xwell.com, the updated platform unites XWELL's health, wellness, and beauty brands — Xpres Spa®, Naples Wax Center®, XpresCheck®, and HyperPointe™ — under one cohesive experience. Visitors can now explore locations, connect with spa staff, and book services, all in a few clicks. "This new website is a reflection of where XWEL

    7/29/25 8:00:00 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    Financials

    Live finance-specific insights

    View All

    XWELL Reports Second Quarter 2025 Results

    NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced results for the second quarter ended June 30, 2025. From providing critical biosecurity support to building tech-forward wellness spaces in transportation hubs and local communities, XWELL currently is on a growth trajectory. Through its portfolio of in-airport and off-airport brands, the Company is reimagining what it means to access wellness. Operating Highlights Revenue for the 2025 second quarter totaled $7.7 millionCost of sales decreased approximately 5% from the 2024 second quarterGeneral and administrativ

    8/14/25 4:30:31 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL, Inc. to Report Second Quarter 2025 Results on Thursday, August 14, 2025

    NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced that it will report second quarter 2025 financial results on Thursday, August 14, 2025, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m. ET. The Company encourages investors, and interested parties, to listen via webcast, as there is a limited capacity to access the conference call by dialing 1-412-317-6026. The live and later archived webcast can be accessed from the Investor Relations section of the Company's website at https://www.xwell.com. Visitors to the

    8/13/25 4:30:42 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL Reports First Quarter 2025 Results, Advancing Mission to Liberate Science-Proven Wellness

    NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a pioneer in science-proven, accessible wellness, today reported results for the first quarter ended March 31, 2025. With a growing portfolio of in-airport and off-airport wellness brands, XWELL continues to redefine what wellness access looks like --connecting high-impact, science-backed care to everyday consumers wherever they are. From leading the nation's biosecurity response to building tech-forward wellness spaces in transportation hubs and neighborhoods alike, XWELL is extending wellness beyond the elite and into real life. Operating Highlights: Reported first quarter 2025 revenue of $

    5/20/25 4:15:18 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by XWELL Inc.

    SC 13D/A - XWELL, Inc. (0001410428) (Subject)

    8/13/24 5:18:44 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    SEC Form SC 13G filed by XWELL Inc.

    SC 13G - XWELL, Inc. (0001410428) (Subject)

    8/9/24 4:05:23 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by XWELL Inc.

    SC 13D/A - XWELL, Inc. (0001410428) (Subject)

    7/22/24 6:11:01 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary